5-HTT independent effects of fluoxetine on neuroplasticity

Autor: Corinne Poilbout, Gunter Kenis, Marion J. F. Levy, F. Boulle, Laurence Lanfumey, Harry W.M. Steinbusch, Daniel L.A. van den Hove, M. B. Emerit
Přispěvatelé: Academic Affairs, Faculteit FHML Centraal, RS: MHeNs - R3 - Neuroscience, Psychiatrie & Neuropsychologie, MUMC+: MA Niet Med Staf Psychiatrie (9)
Rok vydání: 2019
Předmět:
0301 basic medicine
lcsh:Medicine
Tropomyosin receptor kinase B
Hippocampus
ACTIVATION
Mice
0302 clinical medicine
SYNAPTIC PLASTICITY
Neurotrophic factors
TYROSINE KINASE-B
lcsh:Science
Receptor
Serotonin transporter
GENE-EXPRESSION
Mice
Knockout

Serotonin Plasma Membrane Transport Proteins
Membrane Glycoproteins
Neuronal Plasticity
Multidisciplinary
biology
Depression
Kinase
Chemistry
MOUSE MODEL
Protein-Tyrosine Kinases
ANTIDEPRESSANT DRUGS
MESSENGER-RNA
Signal Transduction
medicine.drug
medicine.medical_specialty
Article
03 medical and health sciences
Fluoxetine
Internal medicine
Neuroplasticity
medicine
Animals
RECEPTOR
Brain-Derived Neurotrophic Factor
lcsh:R
030104 developmental biology
Endocrinology
POSTMORTEM BRAIN
nervous system
Synaptic plasticity
biology.protein
lcsh:Q
030217 neurology & neurosurgery
NEUROTROPHIC FACTOR
Zdroj: Scientific Reports, 9:6311. Nature Publishing Group
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
ISSN: 2045-2322
Popis: Selective serotonin reuptake inhibitors are among the most prescribed antidepressants. Fluoxetine is the lead molecule which exerts its therapeutic effects, at least in part, by promoting neuroplasticity through increased brain-derived neurotrophic factor (BDNF)/tropomyosin-related receptor kinase B (TrkB) signalling. It is unclear however, to which extent the neuroplastic effects of fluoxetine are solely mediated by the inhibition of the serotonin transporter (5-HTT). To answer this question, the effects of fluoxetine on neuroplasticity were analysed in both wild type (WT) and 5-Htt knock-out (KO) mice. Using Western blotting and RT-qPCR approaches, we showed that fluoxetine 10 µM activated BDNF/TrkB signalling pathways in both CD1 and C57BL/6J mouse primary cortical neurons. Interestingly, effects on BDNF signalling were observed in primary cortical neurons from both 5-Htt WT and KO mice. In addition, a 3-week in vivo fluoxetine treatment (15 mg/kg/d; i.p.) increased the expression of plasticity genes in brains of both 5-Htt WT and KO mice, and tended to equally enhance hippocampal cell proliferation in both genotypes, without reaching significance. Our results further suggest that fluoxetine-induced neuroplasticity does not solely depend on 5-HTT blockade, but might rely, at least in part, on 5-HTT-independent direct activation of TrkB.
Databáze: OpenAIRE